Loading…
Park Medi World (PARKHOSPS)₹264.06+1.51%Hospital
In the Jun 2026 quarter (consolidated), Park Medi World reported sales of ₹475 Cr, up 19.3% from Jun 2025, and net profit of ₹89.13 Cr, up 34.7% year on year. For the year to Mar 2026, sales were ₹1,676 Cr and net profit ₹275 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 348 | 353 | 398 | 409 | 409 | 459 | 475 |
| Expenses | 265 | 265 | 294 | 297 | 311 | 333 | 350 |
| Operating Profit | 82.98 | 87.96 | 105 | 113 | 98.84 | 127 | 126 |
| OPM % | 24.0% | 25.0% | 26.0% | 27.0% | 24.0% | 28.0% | 26.0% |
| Other Income | 14.99 | 8.99 | 6.99 | 7.99 | 8.99 | 7.99 | 7.99 |
| Interest | 16.01 | 16.01 | 14.99 | 15.01 | 15.01 | 14.01 | 10.01 |
| Depreciation | 14.93 | 15.93 | 14.94 | 14.95 | 14.95 | 17.92 | 18.91 |
| Profit before tax | 66.88 | 65.91 | 81.93 | 90.89 | 77.89 | 103 | 105 |
| Tax % | 32.1% | 20.0% | 20.1% | 14.1% | 32.1% | 26.0% | 16.1% |
| Net Profit | 46.09 | 52.08 | 66.17 | 79.23 | 53.13 | 77.21 | 89.13 |
| EPS (Rs) | 2.98 | 1.18 | 1.52 | 1.92 | 1.18 | 1.65 | 1.92 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|
| Sales | 764 | 1,082 | 1,252 | 1,229 | 1,392 | 1,676 | 1,752 |
| Expenses | 457 | 740 | 863 | 918 | 1,017 | 1,235 | 1,290 |
| Operating Profit | 309 | 345 | 391 | 311 | 375 | 444 | 464 |
| OPM % | 40.0% | 32.0% | 31.0% | 25.0% | 27.0% | 26.0% | 26.5% |
| Other Income | 2.99 | 8.98 | 14.99 | 28.95 | 29.96 | 31.95 | 32.96 |
| Interest | 24.01 | 40.01 | 51.05 | 72.06 | 61.06 | 59.01 | 54.04 |
| Depreciation | 23.91 | 34.84 | 40.81 | 50.82 | 57.74 | 61.71 | 66.73 |
| Profit before tax | 265 | 278 | 315 | 218 | 287 | 355 | 377 |
| Tax % | 26.1% | 28.1% | 28.1% | 30.1% | 26.0% | 23.0% | — |
| Exceptional items | 0.00 | 0.00 | −2.01 | −1.01 | −1.01 | 0.00 | — |
| Net Profit | 187 | 199 | 229 | 152 | 213 | 275 | 299 |
| EPS (Rs) | 80.79 | 11.79 | 14.34 | 10.00 | 5.36 | 5.99 | 6.67 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 18.99 | 77.11 | 77.14 | 77.05 | 77.01 | 85.92 |
| Reserves | 257 | 381 | 612 | 809 | 996 | 1,940 |
| Borrowings | 292 | 517 | 577 | 687 | 682 | 364 |
| Other Liabilities | 250 | 321 | 333 | 345 | 384 | 429 |
| Total Liabilities | 818 | 1,296 | 1,598 | 1,917 | 2,139 | 2,819 |
| Fixed Assets | 365 | 459 | 537 | 838 | 899 | 1,310 |
| CWIP | 7.03 | 29.11 | 5.01 | 32.10 | 37.13 | 124 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 445 | 809 | 1,056 | 1,046 | 1,203 | 1,385 |
| Inventories | 7.97 | 5.98 | 1.99 | 1.99 | 2.99 | 2.99 |
| Trade receivables | 316 | 449 | 576 | 511 | 615 | 594 |
| Cash & equivalents | 89.14 | 192 | 203 | 391 | 361 | 432 |
| Total Assets | 818 | 1,296 | 1,598 | 1,917 | 2,139 | 2,819 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 222 | 155 | 198 | 366 | 190 | 328 |
| Cash from investing activity | −234 | −249 | −235 | −76.27 | −91.36 | −335 |
| Cash from financing activity | 48.87 | 162 | 0.99 | −130 | −73.81 | 121 |
| Net cash flow | 39.10 | 70.23 | −34.13 | 162 | 26.08 | 116 |
| Capex | 138 | 93.22 | 98.20 | 71.12 | 159 | 120 |
| Free cash flow | 86.29 | 64.20 | 106 | 300 | 66.17 | 209 |
| CFO / OP % | 96.1% | 72.1% | 76.1% | 150.1% | 74.1% | 96.1% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 152 | 152 | 169 | 152 | 162 | 130 |
| Inventory days | 48 | 15 | 4 | 4 | — | 5 |
| Days payable | 122 | 102 | 111 | 134 | — | 135 |
| Cash conversion cycle | 77 | 64 | 61 | 21 | 161 | −2 |
| Working capital days | 39 | 59 | 39 | 20 | 30 | 27 |
| ROCE % | — | 37.9% | 30.9% | 19.9% | 20.0% | 19.0% |
For the Jun 2026 quarter, Park Medi World reported sales of ₹475 Cr, up 19.3% year on year and net profit of ₹89.13 Cr, up 34.7% year on year. The operating margin was 26.0%.
Park Medi World's sales for the year to Mar 2026 were ₹1,676 Cr; over the last twelve months they were ₹1,752 Cr.
Net profit for the year to Mar 2026 was ₹275 Cr, and ₹299 Cr over the last twelve months. Earnings per share over the same trailing period were ₹6.67.
Park Medi World reported borrowings of ₹364 Cr at Mar 2026, against cash and equivalents of ₹432 Cr.
Cash from operations was ₹328 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹209 Cr.